A retrospective-prospective study assessing the metabolizer profile of cytochrome isoforms in Gaucher's-disease-type-I patients treated with Eliglustat and to analyze interferences with concomitant therapies
Latest Information Update: 19 Aug 2021
At a glance
- Drugs Eliglustat (Primary) ; Imiglucerase (Primary) ; Miglustat (Primary) ; Velaglucerase alfa (Primary)
- Indications Gaucher's disease type I
- Focus Pharmacokinetics
- 25 Aug 2021 Results published in the Chemico-Biological Interactions
- 19 Aug 2021 New trial record